DIA
Drug Information Association Logo
« Back to Listing

Product Crisis Management: Crisis, What Crisis?

Track:
Clinical Safety and Pharmacovigilance

Day & Time:
June 18, 3:30PM - 5:00PM (Pacific Standard Time)

Session Number:
396

Room Number:
30AB

Level:
Intermediate

Type:
Session

Title:
Product Crisis Management: Crisis, What Crisis?

Chair(s):
Mariette Boerstoel-Streefland, MD, MBA, MS
Head, Global Safety and Pharmacovigilance
Baxter International Inc. , United States

Description:
What is a product crisis, and how can a pharmaceutical company best prepare and react? Principles for crisis management and communication will be discussed, with specific examples provided. Insight into crisis management in other industries will be given.

Learning Objective(s):
Explain what constitutes a product crisis; Describe the best practices in the pharmaceutical industry to manage a product crisis; Discuss how to arrive at an effective crisis communication plan; Determine who are the players in case of a crisis; Describe what is being done in other industries including what can be learned by the pharmaceutical industry.

Presentation(s) & Speaker(s):
Planning for the Unexpected: Product Crisis Management
Cesare Pinto
Deputy Director, Customer Care Services
Bayer HealthCare Pharmaceuticals, United States

Dousing the Flames: Audience-Directed Interventions for Crisis Communications
Gil Bashe
Executive Vice President, Health
Makovsky Health, United States

Pharmacovigilance: Planning for a Pandemic
Libbie Parker McKenzie, MD
Executive Director, Safety Knowledge and Reporting
Quintiles Inc., United States